IPO Readiness at Goodwin

In partnership with Toppan Merrill, we created this IPO guide as an “all-in-one-place” resource to the IPO. It comprehensively covers topics including legal and regulatory frameworks, preparation and due diligence, pricing and allocation, and post-IPO obligations and opportunities. It also includes practical tips and checklists to help you navigate the IPO journey with confidence and efficiency.

You can download the guide for free by filling out a simple form. We hope you find this guide useful and informative.

• IPO Launchpad: Executive Guide to Going Public | October 16, 2024 | Boston
  Please join Goodwin, EY and industry leaders for an informative afternoon designed to equip you with essential knowledge and strategies to successfully navigate the complexities of a potential public offering. The event will feature a market update, insights into current IPO trends, and key considerations for IPO readiness and strategic alternatives. Be a part of this opportunity to stay ahead in the evolving landscape of public offerings. If you’re interested in this invitation only event, please click here.
• IPO Launchpad: Executive Guide to Going Public | November 18, 2024 | London
  Please join Goodwin’s Life Sciences practice for a life sciences-focused IPO workshop, where industry leaders will share their insights and expertise to guide you through the complexities of taking a company public. Our distinguished line-up of speakers, includes top legal, business, PR and financial experts who will provide invaluable knowledge and guidance. If you’re interested in this invitation only event, please click here.

• Biotech on Tap 2024 | September 24-27, 2024 | Munich, Germany
  This annual event features two days of insightful industry panels, keynote speakers and networking opportunities and will conclude with festivities at one of the most famous venues at Oktoberfest, the Hofbräu Festzelt. If you’re interested in this invitation only event, please click here.

• CFGI Boston Life Sciences IPOs and the Capital Markets Landscape | September 10, 2024 | Boston
  This IPO-focused discussion for life sciences companies will feature Jay Clayton, former SEC Chair, as well as additional panelists. You will be able to hear from industry leaders on their insights on the capital markets landscape as well as the state of, and strategies for, navigating the current economic environment. If you’re interested in this invitation only event, please click here.

• IPO Bootcamp Philadelphia | May 15, 2024 | KPMG Philadelphia Conference Center
  Join us for our IPO bootcamp hosted in partnership with KPMG, JP Morgan & NASDAQ
On May 15, between 8:30 AM and 1:00 PM, a panel of IPO insiders and seasoned experts will provide you with a comprehensive update on the swiftly evolving IPO market and offer their predictions for what to expect in Q2 & Q3 of 2024. Discover valuable insights about the intricacies of going public, factors to consider before and after the pre-organizational meeting, and strategies to effectively maintain your team’s optimal performance post-offering.

• LSX Virtual IPO Bootcamp | April 16, 2024 | Virtual
  Goodwin Life Sciences is an exclusive sponsor of the LSX Virtual IPO Bootcamp that takes place annually a couple of times per year. It is an invitation only online workshop and series of 1:1 consultation. It provides CEOs and CFOs of life science companies contemplating a US IPO a unique opportunity to come together for a series of frank and open discussions with peers, case studies from executives who have recently been through the process, and for tailored and 1-2-1 advice with the region’s foremost experts, advisers, bankers, and consultants. The US IPO Bootcamp is by invitation only for qualifying companies. If interested to participate in the future, please click here and apply. Goodwin partners Ariel White-Tsimikalis and Marishka DeToy will join the virtual roundtable discussion.
  
  Please contact MMuress@goodwinlaw.com to put any interested companies in touch with LSX for consideration.
  
  
• Goodwin + KPMG Symposium @ JPMorgan | January 10, 2024, InterContinental SF, 5th floor
  Goodwin and KPMG hosted their 5th Annual Symposium on January 10, 2024, during the 42nd Annual JP Morgan Healthcare Conference. Experts and practitioners delved into strategies that are enabling life sciences companies to enhance research and development; optimize value from licensing, M&A, and other transactions; and secure capital for growth. Learn more about the key takeaways and watch featured videos from our latest symposium.
  
   
• KPMG IPO Bootcamp Boston 2023 | November 17, 2023 | KPMG Boston Office
  KPMG hosted their Boston IPO Bootcamp 2023 with a panel of IPO insiders and seasoned experts who provided a comprehensive update on the swiftly evolving IPO market and offered predictions for what to expect in Q4 2023 and 2024. Bill Collins and Gregg Katz spoke alongside esteemed representatives from Nasdaq and JP Morgan.
  
  For more information, please contact Martina Boyce.
  
  
• IPO Bootcamp at Jefferies HC Conference with ICR Consilium | November 13, 2023 | Chartered Accountants Hall, London
  Goodwin and ICR Consilium hosted an exclusive Healthcare IPO Bootcamp, where industry leaders shared their insights and expertise on the complexities of taking a company public. Our distinguished line-up of speakers included top business leaders who have successfully taken a company through IPO and legal, business, financial, and communications experts who have invaluable knowledge and guidance. Goodwin partner Marishka DeToy spoke at the event.
  
  
• PwC + Workiva IPO Readiness Workshop | November 8, 2023 | PwC Boston Office
  PwC and Workiva hosted a workshop highlighted market conditions and key trends, valuation considerations and discussion of KPI and non-GAAP metrics, and IPO considerations. Goodwin partners Stephanie Richards and Gregg Katz spoke to IPO considerations such as organizing a meeting, timelines, disclosure requirements, key players, and more.
  
  
• LSX IPO Bootcamp | November 7, 2023 | Virtual
  This bootcamp centered on a US IPO case study surrounding the process and experience of taking Oculis public in the US in 2023. We discussed alternative considerations to a traditional IPO in a challenging market, when decision-making should happen, what usually makes an EU or a non-US company a good candidate for a successful Nasdaq IPO, and what the timeline looks like once a company has decided to go down the IPO route.
  
  
• Nomura Private Company IPO Readiness Day | November 2, 2023 | Goodwin Silicon Valley Office
  Goodwin co-hosted with Nomura to offer a Private Company Showcase and IPO bootcamp, which discussed the latest IPO trends and ins and outs of going public. The event involved speakers from Nomura, Deloitte, Goodwin and a number of company contacts that have recently gone public. Partners involved include Ben Marsh, Deepa Rich, Bryan Quinn, and Marianne Sarrazin.
  
  For more information, please contact Marisa Sandler.
  
  
• Private Company Showcase | October 12, 2023 | Goodwin New York Office
  The Private Company Showcase was hosted by BMO, ICR Westwicke, and Goodwin in NYC. The showcase took place in-person and included some of the most exciting private life sciences company presentations, thematic panels, and one-on-one meetings between investors and some of the most exciting private life sciences companies. The program concluded with a cocktail reception as an opportunity for participants to network with one another. Goodwin partner Ben Marsh was involved and attended the event and reception.
  
  For more information, please contact Marisa Sandler or Martina Boyce. Please view the recordings from the introduction and morning panel and the lunch panel.
  
  
• Going Public Workshop Co-Hosted by Goodwin and Deloitte | October 10, 2023 | Goodwin Boston Office
  This workshop was co-hosted by Goodwin and Deloitte and designed for C-Suite executives and finance leaders of companies contemplating a public exit within the near future. Join us as leaders from organizations well-versed in the IPO, SPAC, and direct listing processes share market insights as we look towards 2024 transactions. We will discuss market conditions, regulatory considerations, leading practices to prepare for a public exit including timetable, life as a public company, and insights from executives at companies that recently became public. Partners involved include Gabriela Morales-Rivera, Gregg Katz, and Joe Theis.
  
  For more information, please contact Natalie Boyle and Colleen Majarian. You can access the recording here.

To view the full PDF: IPO Timeline: Key Stages

To view the full PDF:  IPO Process